Compare LXEO & TSSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LXEO | TSSI |
|---|---|---|
| Founded | 2017 | 2004 |
| Country | United States | United States |
| Employees | N/A | 161 |
| Industry | | Professional Services |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 369.8M | 315.9M |
| IPO Year | 2023 | N/A |
| Metric | LXEO | TSSI |
|---|---|---|
| Price | $5.16 | $16.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $18.44 | $16.00 |
| AVG Volume (30 Days) | 667.0K | ★ 1.4M |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.81 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $654,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.67 |
| P/E Ratio | ★ N/A | $42.71 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.72 | $6.87 |
| 52 Week High | $10.99 | $31.94 |
| Indicator | LXEO | TSSI |
|---|---|---|
| Relative Strength Index (RSI) | 43.41 | 66.45 |
| Support Level | $4.95 | $13.98 |
| Resistance Level | $6.26 | $21.38 |
| Average True Range (ATR) | 0.38 | 0.97 |
| MACD | 0.00 | 0.36 |
| Stochastic Oscillator | 36.34 | 88.57 |
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.
TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: Procurement, Systems Integration, and Facilities Management. It generates the majority of its revenue from the Procurement segment.